A price target is what analysts use to project how high they expect a stock to climb within a set period. UBS lowered that number for Boston Scientific while keeping its buy rating on the shares unchanged. The bank still recommends the stock but now sees a smaller potential gain.

What a buy rating and a price target each mean

A buy rating is a formal recommendation telling clients the stock is worth owning. UBS has kept that call on Boston Scientific in place.

A price target does different work. It is the specific level the analyst expects the stock to reach, the number that defines how much upside the buy call implies. When that number falls while the rating stays, the directional view holds but the projected return shrinks.

Investors sometimes read a maintained buy rating as a clean green light. The target tells the more precise story. A buy recommendation paired with a lower target is a more conservative position than the same buy paired with a higher one, even when the headline label does not change.

What this revision confirms and what it does not

UBS lowered its price target for Boston Scientific and maintained its buy rating. Those are the two confirmed facts.

The source does not provide the prior target, the revised figure, or the stated reason for the change. Without those numbers, the scale of the revision cannot be assessed here. What the move puts on record is that UBS now sees less upside in Boston Scientific than before, while still recommending the stock to clients.

Related reading